
April to June 2022
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| AFLIBERCEPT | $128,850,286 | 108,111 |
| PEMBROLIZUMAB | $110,535,210 | 13,049 |
| NIVOLUMAB | $97,660,047 | 12,982 |
| USTEKINUMAB | $79,172,007 | 11,046 |
| ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR | $74,423,245 | 3,484 |
| APIXABAN | $70,949,859 | 885,954 |
| ADALIMUMAB | $70,840,833 | 79,094 |
| DENOSUMAB | $68,224,032 | 273,627 |
| MOLNUPIRAVIR | $63,331,277 | 58,478 |
| LENALIDOMIDE | $61,494,724 | 11,200 |
| OCRELIZUMAB | $50,406,525 | 2,905 |
| DUPILUMAB | $48,381,422 | 28,337 |
| Drug Name | Government Contribution Dollars | Prescriptions |
|---|---|---|
| ROSUVASTATIN | $22,098,165 | 3,954,531 |
| ATORVASTATIN | $18,356,914 | 3,021,465 |
| PANTOPRAZOLE | $14,722,089 | 2,490,033 |
| ESOMEPRAZOLE | $18,959,265 | 2,095,554 |
| PERINDOPRIL | $9,710,266 | 1,760,911 |
| ESCITALOPRAM | $5,337,570 | 1,494,139 |
| METFORMIN | $9,192,988 | 1,417,617 |
| SERTRALINE | $5,282,212 | 1,392,574 |
| AMOXICILLIN | $4,168,773 | 1,337,504 |
| CEFALEXIN | $4,885,460 | 1,184,213 |
| AMLODIPINE | $5,858,948 | 1,175,354 |
| TELMISARTAN | $5,906,301 | 1,115,699 |
| Contributor | Contribution Dollars |
|---|---|
| Australian Government | $3,757,257,461 |
| Patients | $933,490,993 |